Patents by Inventor George Hui

George Hui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticle Based Immunological Stimulation
    Publication number: 20120189700
    Abstract: A nanoparticle-based delivery system and methods for its use are disclosed. In one aspect, a nanoparticle-based delivery system comprising at least one molecule such as proteins, DNA/RNA or fragments thereof, carbohydrates, enzymes, chemicals, virus cells, bacteria, parts of a virus, parts of a bacteria, parts of a cell, part of a tissue, or a combination of one or more of these, which shall be referred to as immunogens, are chemically or physically combined with water soluble nanoparticles which, when administered to a living system, is capable of eliciting a desired immunological response. More particularly, the invention relates to nanoparticle-based delivery systems that are specifically engineered to enhance humoral or cellular immune response without the use of adjuvants.
    Type: Application
    Filed: January 16, 2012
    Publication date: July 26, 2012
    Inventors: Zoraida Aguilar, Yongqiang Wang, Hengyi Xu, George Hui, Kae Pusic
  • Malaria recombinant poxvirus vaccine
    Patent number: 6214353
    Abstract: What is described is a recombinant poxvirus, such as vaccinia virus, containing foreign DNA from Plasmodium Merozoite Surface Antigen 1. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
    Type: Grant
    Filed: May 21, 1998
    Date of Patent: April 10, 2001
    Assignees: Pasteur Merieux Serums et Vaccins, The University of Hawaii
    Inventors: Enzo Paoletti, Charles de Taisne, Sandra Chang, George Hui, Wasim A. Siddigui
  • Malaria recombinant poxvirus
    Patent number: 5756101
    Abstract: What is described is a recombinant poxvirus, such as vaccinia virus, containing foreign DNA from Plasmodium Merozoite Surface Antigen 1. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine.
    Type: Grant
    Filed: January 7, 1994
    Date of Patent: May 26, 1998
    Assignees: Pasteur Merieux serums et Vaccins, University of Hawaii
    Inventors: Enzo Paoletti, Charles de Taisne, Sandra Chang, George Hui, Wasim Siddiqui